PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-06-30

Date Title Company
30-Jun-2025 MedMira Reports Second Quarter Results FY2025 ACCESS Newswire
30-Jun-2025 (UPDATED) Best Creatine For Women Over 40: Creatine Supplement Impact on Menopause ACCESS Newswire
30-Jun-2025 aap Implantate AG closes financial year 2024 successfully - positive developments despite challenging environment aap Implantate AG
30-Jun-2025 Annual Results 2024 bonyf NV
30-Jun-2025 Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity ACCESS Newswire
30-Jun-2025 TRANSPLANT HOPE: NEW TECH TO ASSESS VIABILITY OF DONOR KIDNEYS Accunea
30-Jun-2025 HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy HUTCHMED
30-Jun-2025 OncoZenge: Investor Receives State Administration of Foreign Exchange (SAFE) Approval OncoZenge:
30-Jun-2025 Insights from Exceptional Cancer Survivors: Cure51 Partners with French Bordeaux-based Contract research Organisation Explicyte to proceed with spatial analysis of exceptional Cancer survivors Samples from 40 Countries Cure51
30-Jun-2025 Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Riliprubart
30-Jun-2025 ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP ProQR
30-Jun-2025 Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics to Advance Precision Medicine Neurodevelopmental Disorder Programs Stalicla
30-Jun-2025 STORM Therapeutics Appoints Veteran Cancer Drug Developer Dr. Eric Martin as Chief Development Officer STORM Therapeutics
30-Jun-2025 Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of THC and CBD Formulations Tilray Medical
30-Jun-2025 UCB announces positive results from GEMZ phase 3 study of fenfluramine in CDKL5 Deficiency Disorder UCB
30-Jun-2025 Viromed Medical AG expects dynamic growth and announces forecast for 2025 and 2026 Viromed Medical AG
30-Jun-2025 ANGLE PLC Announces Result of 2025 Annual General Meeting ACCESS Newswire
30-Jun-2025 New Report Analyzes Gaps in State Health Insurance and AI Consumer Protections ACCESS Newswire
30-Jun-2025 BULLETIN from EXTRAORDINARY GENERAL MEETING in Senzime AB (publ) ACCESS Newswire
30-Jun-2025 Original-Research: Marinomed Biotech AG (von First Berlin Equity Research GmbH) Marinomed Biotech AG